<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38709747</article-id><article-id pub-id-type="pmc">11073708</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0302896</article-id><article-id pub-id-type="publisher-id">PONE-D-23-42962</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Covid 19</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Radiology and Imaging</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Elements</subject><subj-group><subject>Oxygen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Health Care</subject><subj-group><subject>Health Care Facilities</subject><subj-group><subject>Hospitals</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Materials Science</subject><subj-group><subject>Material Properties</subject><subj-group><subject>Optical Properties</subject><subj-group><subject>Opacity</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Virus Testing</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pulmonology</subject><subj-group><subject>Pulmonary Function</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Mathematical and Statistical Techniques</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Metaanalysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Metaanalysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>CT abnormalities 3 and 12 months after hospitalization for COVID-19 and association with disease severity: A prospective cohort study</article-title><alt-title alt-title-type="running-head">CT abnormalities 3 and 12 months after hospitalization for COVID-19</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Aal&#xF8;kken</surname><given-names>Trond Mogens</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ashraf</surname><given-names>Haseem</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Einvik</surname><given-names>Gunnar</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lerum</surname><given-names>T&#xF8;ri Vigeland</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Meltzer</surname><given-names>Carin</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rodriguez</surname><given-names>Jezabel Rivero</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Skj&#xF8;nsberg</surname><given-names>Ole Henning</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4512-8000</contrib-id><name><surname>Stavem</surname><given-names>Knut</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/software/">Software</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff004" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff007" ref-type="aff">
<sup>7</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Radiology and Nuclear Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Institute of Clinical Medicine, University of Oslo, Oslo, Norway</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Diagnostic Imaging, Akershus University Hospital, L&#xF8;renskog, Norway</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Pulmonary Department, Akershus University Hospital, L&#xF8;renskog, Norway</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Department of Pulmonary Medicine, Oslo University Hospital Ullev&#xE5;l, Oslo, Norway</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Department of Radiology and Nuclear Medicine, Oslo University Hospital Ullev&#xE5;l, Oslo, Norway</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Health Services Research Unit, Akershus University Hospital, L&#xF8;renskog, Norway</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Zhu</surname><given-names>Julie</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>Dalhousie University Faculty of Medicine, CANADA</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>Haseem Ashraf reports grant from Boehringer-Ingelheim, Norway. Knut Stavem reports personal fees from UCB Pharma and MSD Norway, unrelated to this study.</p></fn><corresp id="cor001">* E-mail: <email>knut.stavem@medisin.uio.no</email></corresp></author-notes><pub-date pub-type="epub"><day>6</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>19</volume><issue>5</issue><elocation-id>e0302896</elocation-id><history><date date-type="received"><day>28</day><month>12</month><year>2023</year></date><date date-type="accepted"><day>12</day><month>4</month><year>2024</year></date></history><permissions><copyright-statement>&#xA9; 2024 Aal&#xF8;kken et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Aal&#xF8;kken et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0302896.pdf"/><abstract><sec id="sec001"><title>Objectives</title><p>To investigate changes in chest CT between 3 and 12 months and associations with disease severity in patients hospitalized for COVID-19 during the first wave in 2020.</p></sec><sec id="sec002"><title>Materials and methods</title><p>Longitudinal cohort study of patients hospitalized for COVID-19 in 2020. Chest CT was performed 3 and 12 months after admission. CT images were evaluated using a CT severity score (CSS) (0&#x2013;12 scale) and recoded to an abbreviated version (0&#x2013;3 scale). We analyzed determinants of the abbreviated CSS with multivariable mixed effects ordinal regression.</p></sec><sec id="sec003"><title>Results</title><p>242 patients completed CT at 3 months, and 124 (mean age 62.3&#xB1;13.3, 78 men) also at 12 months. Between 3 and 12 months (n = 124) CSS (0&#x2013;12 scale) for ground-glass opacities (GGO) decreased from median 3 (25<sup>th</sup>&#x2013;75<sup>th</sup> percentile: 0&#x2013;12) at 3 months to 0.5 (0&#x2013;12) at 12 months (p&lt;0.001), but increased for parenchymal bands (p&lt;0.001). In multivariable analysis of GGO, the odds ratio for more severe abbreviated CSS (0&#x2013;3 scale) at 12 months was 0.11 (95%CI 0.11 0.05 to 0.21, p&lt;0.001) compared to 3 months, for WHO severity category 5&#x2013;7 (high-flow oxygen/non-invasive ventilation/ventilator) versus 3 (non-oxygen use) 37.16 (1.18 to 43.47, p = 0.032), and for age &#x2265;60 compared to &lt;60 years 4.8 (1.33 to 17.6, p = 0.016). Mosaicism was reduced at 12 compared to 3 months, OR 0.33 (95%CI 0.16 to 0.66, p = 0.002).</p></sec><sec id="sec004"><title>Conclusions</title><p>GGO and mosaicism decreased, while parenchymal bands increased from 3 to 12 months. Persistent GGO were associated with initial COVID-19 severity and age &#x2265;60 years.</p></sec></abstract><funding-group><award-group id="award001"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100008349</institution-id><institution>Boehringer Ingelheim</institution></institution-wrap>
</funding-source><principal-award-recipient>
<name><surname>Ashraf</surname><given-names>Haseem</given-names></name>
</principal-award-recipient></award-group><funding-statement>This study had financial support from Boehringer-Ingelheim, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="3"/><page-count count="16"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>Data availability: The ethical approval granted by the Regional Committees for Medical and Health Research Ethics in Norway does not allow public sharing of the data. A data set can be made available for scientific analysis on request, provided data is handled in accordance with ethical regulations (written ethics protocol, full compliance with the Declaration of Helsinki). To ensure full anonymity only the main variables of the final analyses are provided. We confirm that the data file provided constitutes the minimal data set necessary to replicate the findings of our study in their entirety. Data requests can be made to corresponding author Knut Stavem (<email>knut.stavem@medisin.uio.no</email>) or data custodian, Haldor Husby (<email>haldor.husby@ahus.no</email>).</meta-value></custom-meta><custom-meta id="outbreaks"><meta-name>Outbreaks</meta-name><meta-value>COVID-19</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>Data availability: The ethical approval granted by the Regional Committees for Medical and Health Research Ethics in Norway does not allow public sharing of the data. A data set can be made available for scientific analysis on request, provided data is handled in accordance with ethical regulations (written ethics protocol, full compliance with the Declaration of Helsinki). To ensure full anonymity only the main variables of the final analyses are provided. We confirm that the data file provided constitutes the minimal data set necessary to replicate the findings of our study in their entirety. Data requests can be made to corresponding author Knut Stavem (<email>knut.stavem@medisin.uio.no</email>) or data custodian, Haldor Husby (<email>haldor.husby@ahus.no</email>).</p></notes></front>
  <body>
    <sec sec-type="intro" id="sec005">
      <title>Introduction</title>
      <p>Computed tomography (CT) provides detailed information about the extent and pattern of lung involvement in COVID-19. In the acute phase, CT scans often reveal ground-glass opacities (GGO), consolidations, and other signs of inflammation [<xref rid="pone.0302896.ref001" ref-type="bibr">1</xref>&#x2013;<xref rid="pone.0302896.ref003" ref-type="bibr">3</xref>]. There is a considerable concern for sequelae in survivors, particularly reduced lung function and structural changes, such as chronic pulmonary fibrosis [<xref rid="pone.0302896.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0302896.ref005" ref-type="bibr">5</xref>].</p>
      <p>Recent reviews and meta-analyses of CT findings 6&#x2013;12 months after COVID- have reported a wide range of prevalence rates for post-COVID-19 CT abnormalities [<xref rid="pone.0302896.ref006" ref-type="bibr">6</xref>&#x2013;<xref rid="pone.0302896.ref008" ref-type="bibr">8</xref>]. After 1 year, the prevalence of chest CT lung sequelae ranges from 7&#x2013;97%, with GGO ranging from 2&#x2013;68% [<xref rid="pone.0302896.ref008" ref-type="bibr">8</xref>]. Fibrotic-like findings are also common and show little change in prevalence 4&#x2013;7-months to 1 year after COVID-19 [<xref rid="pone.0302896.ref007" ref-type="bibr">7</xref>]. Most studies with 1-year follow-up have reported the prevalence or change in overall or specific CT abnormalities [<xref rid="pone.0302896.ref009" ref-type="bibr">9</xref>&#x2013;<xref rid="pone.0302896.ref013" ref-type="bibr">13</xref>]. Some studies also investigated determinants of persistent CT abnormalities, such as fibrosis, in multivariable logistic regression models [<xref rid="pone.0302896.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0302896.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0302896.ref014" ref-type="bibr">14</xref>&#x2013;<xref rid="pone.0302896.ref017" ref-type="bibr">17</xref>].</p>
      <p>In interpreting CT images, many studies used systematic scoring systems to describe the severity and distribution of abnormalities [<xref rid="pone.0302896.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0302896.ref019" ref-type="bibr">19</xref>]. These scales are typically qualitative scales with ordinal properties, but they are often dichotomized in further analysis. This approach fails to utilize the full spectrum of available data, thereby diminishing the statistical power of the analyses [<xref rid="pone.0302896.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0302896.ref021" ref-type="bibr">21</xref>]. The striking heterogeneity in findings across studies [<xref rid="pone.0302896.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0302896.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0302896.ref022" ref-type="bibr">22</xref>], to a large extent due to selection bias and publication bias [<xref rid="pone.0302896.ref008" ref-type="bibr">8</xref>], and the underuse of available information, underscores the need for more studies to address the temporal changes in chest CT and the association with disease severity in COVID-19 survivors.</p>
      <p>We have previously presented a cohort of patients hospitalized for COVID-19 in 2020, including follow-up with data on dyspnea, lung function, and a crude analysis of CT abnormalities [<xref rid="pone.0302896.ref017" ref-type="bibr">17</xref>]. The present study aimed to determine the chest CT severity scores and temporal changes for pulmonary CT abnormalities between 3 and 12 months, and to investigate their association with disease severity in multivariable analysis in this cohort.</p>
    </sec>
    <sec sec-type="materials|methods" id="sec006">
      <title>Material and methods</title>
      <sec id="sec007">
        <title>Study design, population and procedures</title>
        <p>All study participants provided informed consent through a paper form or via a secure web-application. The study was approved by the Regional Ethics Committee for South-Eastern Norway (no. 2020/125384) and the Data Protection Officer at each participating hospital. It is registered with ClinicalTrials.gov (NCT 04535154).</p>
        <p>This longitudinal observational cohort study included patients &#x2265;18 years of age recruited from six Norwegian hospitals during the first wave of COVID-19 as part of the &#x201C;Patient-Reported Outcomes and Lung Function After Hospitalization for COVID-19&#x201D; study (PROLUN) [<xref rid="pone.0302896.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0302896.ref023" ref-type="bibr">23</xref>]. Recruitment was consecutive for patients discharged from hospital from 11 March 2020 to 1 June 2020, by obtaining consents 4&#x2013;8 weeks after discharge. We excluded patients that had domicile outside the hospitals&#x2019; catchment areas or participated in a clinical trial.</p>
        <p>Baseline variables during the acute COVID-19 were collected by review of the electronic medical records. Comorbidity was scored using the Charlson comorbidity index [<xref rid="pone.0302896.ref024" ref-type="bibr">24</xref>]. Disease severity was scored using the WHO 8-point ordinal scale for clinical improvement [<xref rid="pone.0302896.ref025" ref-type="bibr">25</xref>] with the following gradations: 3, hospitalized, no oxygen therapy; 4, oxygen by mask or nasal prongs; 5, non-invasive ventilation or high-flow oxygen; 6, intubation and mechanical ventilation; 7, ventilation with additional organ support. For analysis, we used three categories: 3, 4, and 5&#x2013;7.</p>
        <p>All participants were invited to outpatient follow-up visits at 3 and 12 months after hospital admission, including pulmonary function tests, blood sampling, and chest CT. Participants with chest CT findings consistent with COVID-19 sequelae after 3 months had a follow-up scan at 12 months. <xref rid="pone.0302896.g001" ref-type="fig">Fig 1</xref> shows patient recruitment and attrition in the study. Ultimately, 124 patients completed a repeat CT scan at 12 months.</p>
        <fig position="float" id="pone.0302896.g001">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302896.g001</object-id>
          <label>Fig 1</label>
          <caption>
            <title>Flow-chart of patient inclusion and attrition in the study.</title>
          </caption>
          <graphic xlink:href="pone.0302896.g001" position="float"/>
        </fig>
      </sec>
      <sec id="sec008">
        <title>Chest CT protocol, image review, and scoring</title>
        <p>The participating centres used the same volumetric CT protocol across the various CT systems, and images were reconstructed with thin (0.9&#x2013;1.25 mm) section thickness for evaluation. For detailed description of the protocol and image acquisition, see <xref rid="pone.0302896.s001" ref-type="supplementary-material">S1 File</xref>.</p>
        <p>Three thoracic radiologists (T.M.A, C.M., J.R.R.) with at least 10 years of experience reviewed the CT scans from all centres in consensus and in a random order. The observers were blinded to the patient&#x2019;s clinical data. The readers registered the presence, extent, and distribution of CT features using nomenclature recommended by the Fleischner Society [<xref rid="pone.0302896.ref026" ref-type="bibr">26</xref>], including GGO, parenchymal bands, reticular pattern, airspace consolidation, interlobular septal thickening, bronchiectasis and/or bronchiolectasis, and mosaicism.</p>
        <p>The distribution and extent of disease was individually assessed in eight zones, four for each lung (above the aortic arch, between the aortic arch and the level of the carina, between the level of the carina and the level of the left inferior pulmonary vein, and below). The extent of affection in each zone was assigned a score based on the percentage of lung parenchyma with abnormality on a 0&#x2013;3 scale (0, no involvement; 1, minimal; 2, moderate; 3, severe). An overall score of parenchymal involvement for each CT feature for each patient was derived by summing the scores of the four zones to an ordinal chest CT severity score (CSS) ranging from 0 (no involvement) to 12 (maximum involvement). The method was derived from a standardized method for evaluation of interstitial lung disease [<xref rid="pone.0302896.ref027" ref-type="bibr">27</xref>]. For detailed description of the review and scoring, see <xref rid="pone.0302896.s001" ref-type="supplementary-material">S1 File</xref>.</p>
        <p>For regression analysis and easier visualization of changes in the four CT features of the CSS with highest prevalence of abnormalities (&gt;20%), we recoded the CSS into an abbreviated CSS (aCSS) scale ranging from 0 to 3: 0 (none), CSS score of 0; 1 (mild), CSS 1&#x2013;3; 2 (moderate), CSS 4&#x2013;7; and 3 (severe), CSS 8&#x2013;12.</p>
      </sec>
      <sec id="sec009">
        <title>Statistical analysis</title>
        <p>Descriptive statistics are presented using the mean (SD), median (25<sup>th</sup>&#x2013;75<sup>th</sup> percentile), median (range), or number (%). Independent groups were compared using the t-test, chi-squared test, or Fisher&#x2019;s exact test, as appropriate. Paired comparisons of ordinal scores for CT abnormalities between 3 and 12 months after COVID-19 were analysed using the Wilcoxon signed rank test.</p>
        <p>We analysed the aCSS for four CT features (GGO, parenchymal bands, mosaicism, and grade 1 reticular pattern, each scored on a 0&#x2013;3 scale) using multivariable mixed effects ordinal regression analysis, with random effect for patient and fixed effects for other variables. Because there was only one participant with severe involvement (aCSS score 3) for parenchymal bands and reticulation, we combined the moderate/severe levels in these dimensions. As independent variables, we chose WHO severity rating (3, 4, 5&#x2013;7), age (&lt;60 vs &#x2265;60 years), sex, and time of CT assessment (3 vs. 12 months). The number and choice of independent variables in the models were decided prior to the analysis, without statistical variable selection. We assessed whether there was a multiplicative interaction between WHO severity rating and time of CT assessment, but the interaction term was not statistically significant in any of the four models. The results are presented as odds ratios (OR) for being in a higher category of CT severity dimension score. We verified the proportional odds assumption using the Brant and Wolfe-Gould tests. The assumption was acceptable in models without random effects, as these functions cannot account for a mixed model.</p>
        <p>We chose a significance level of 5%, using two-sided test. We used Stata SE version 17.0 (StataCorp. LLC, College Station, TX, USA) for analysis.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="sec010">
      <title>Results</title>
      <p>Participants with repeat CT scans (n = 124) were older than those with CT scans only at 3 months (n = 118), with mean age 62.3 (SD 13.3) and 53.8 (13.9) years, respectively (p&lt;0.001). Those with two CT scans comprised a larger proportion of males, had lower education levels, more severe acute COVID-19, longer hospital stays, and increased need for ventilator treatment (<xref rid="pone.0302896.t001" ref-type="table">Table 1</xref>). The 3-month CT scans were completed median (25<sup>th</sup>&#x2013;75<sup>th</sup> percentile) 96 (84&#x2013;120) days (n = 241) post-admission, and the 12-month scans 398.5(364&#x2013;461) days (n = 124) post-admission.</p>
      <table-wrap position="float" id="pone.0302896.t001">
        <object-id pub-id-type="doi">10.1371/journal.pone.0302896.t001</object-id>
        <label>Table 1</label>
        <caption>
          <title>Demographics, comorbidity and variables during hospitalization for acute COVID-19.</title>
          <p>Mean (SD) unless specified otherwise.</p>
        </caption>
        <alternatives>
          <graphic xlink:href="pone.0302896.t001" id="pone.0302896.t001g" position="float"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">&#xA0;</th>
                <th align="center" rowspan="1" colspan="1">n</th>
                <th align="center" rowspan="1" colspan="1">All Chest-CT at 3 months (n = 242)</th>
                <th align="center" rowspan="1" colspan="1">n</th>
                <th align="center" rowspan="1" colspan="1">Chest-CT at 3 and 12 months (n = 124)</th>
                <th align="center" rowspan="1" colspan="1">n</th>
                <th align="center" rowspan="1" colspan="1">Chest-CT only at 3 months (n = 118)</th>
                <th align="center" rowspan="1" colspan="1">
<break/>
<italic toggle="yes">P</italic>
<xref rid="t001fn001" ref-type="table-fn">*</xref>
</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Age (years)</td>
                <td align="right" rowspan="1" colspan="1">242</td>
                <td align="right" rowspan="1" colspan="1">58.1 (14.2)</td>
                <td align="right" rowspan="1" colspan="1">124</td>
                <td align="right" rowspan="1" colspan="1">62.3 (13.3)</td>
                <td align="right" rowspan="1" colspan="1">118</td>
                <td align="right" rowspan="1" colspan="1">53.8 (13.9)</td>
                <td align="right" rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Sex (males), number (%)</td>
                <td align="right" rowspan="1" colspan="1">242</td>
                <td align="right" rowspan="1" colspan="1">136 (56)</td>
                <td align="right" rowspan="1" colspan="1">124</td>
                <td align="right" rowspan="1" colspan="1">78 (63)</td>
                <td align="right" rowspan="1" colspan="1">118</td>
                <td align="right" rowspan="1" colspan="1">58 (49)</td>
                <td align="right" rowspan="1" colspan="1">0.031</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Norwegian origin, number (%)</td>
                <td align="right" rowspan="1" colspan="1">223</td>
                <td align="right" rowspan="1" colspan="1">161 (72)</td>
                <td align="right" rowspan="1" colspan="1">112</td>
                <td align="right" rowspan="1" colspan="1">85 (76)</td>
                <td align="right" rowspan="1" colspan="1">111</td>
                <td align="right" rowspan="1" colspan="1">76 (68)</td>
                <td align="right" rowspan="1" colspan="1">0.23</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Education, years</td>
                <td align="right" rowspan="1" colspan="1">231</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">118</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">113</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">0.017</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0; &lt;11</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">41 (18)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">27 (23)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">14 (12)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;11&#x2013;13</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">64 (28)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">37 (31)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">27 (24)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;&gt;13</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">126 (54)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">54 (46)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">72 (64)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Smoking status</td>
                <td align="right" rowspan="1" colspan="1">222</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">112</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">110</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">0.74</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;Never</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">129 (58)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">62 (55)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">67 (61)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;Previous smoker</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">87 (39)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">47 (42)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">40 (36)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;Current smoker</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">6 (3)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">3 (3)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">3 (3)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Comorbidity</italic>
</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Previous myocardial infarction</td>
                <td align="right" rowspan="1" colspan="1">241</td>
                <td align="right" rowspan="1" colspan="1">15 (6)</td>
                <td align="right" rowspan="1" colspan="1">124</td>
                <td align="right" rowspan="1" colspan="1">11 (9)</td>
                <td align="right" rowspan="1" colspan="1">117</td>
                <td align="right" rowspan="1" colspan="1">4 (3)</td>
                <td align="right" rowspan="1" colspan="1">0.08</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Congestive heart failure</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">&#xA0;124</td>
                <td align="right" rowspan="1" colspan="1">4 (5)</td>
                <td align="right" rowspan="1" colspan="1">117</td>
                <td align="right" rowspan="1" colspan="1">6 (5)</td>
                <td align="right" rowspan="1" colspan="1">0.53</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Diabetes</td>
                <td align="right" rowspan="1" colspan="1">241</td>
                <td align="right" rowspan="1" colspan="1">21 (9)</td>
                <td align="right" rowspan="1" colspan="1">124</td>
                <td align="right" rowspan="1" colspan="1">13 (10)</td>
                <td align="right" rowspan="1" colspan="1">117</td>
                <td align="right" rowspan="1" colspan="1">8 (7)</td>
                <td align="right" rowspan="1" colspan="1">0.32</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td>
                <td align="right" rowspan="1" colspan="1">241</td>
                <td align="right" rowspan="1" colspan="1">8 (3)</td>
                <td align="right" rowspan="1" colspan="1">124</td>
                <td align="right" rowspan="1" colspan="1">4 (3)</td>
                <td align="right" rowspan="1" colspan="1">117</td>
                <td align="right" rowspan="1" colspan="1">4 (3)</td>
                <td align="right" rowspan="1" colspan="1">1.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Charlson comorbidity index</td>
                <td align="right" rowspan="1" colspan="1">241</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">124</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">117</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">0.69</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;0</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">173 (72)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">87 (70)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">86 (74)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;1</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">41 (17)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">21 (17)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">20 (17)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;&#x2265;2</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">27 (11)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">16 (13)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">11 (9)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<italic toggle="yes">At admission</italic>
</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Systolic blood pressure (mmHg)</td>
                <td align="right" rowspan="1" colspan="1">238</td>
                <td align="right" rowspan="1" colspan="1">134 (18)</td>
                <td align="right" rowspan="1" colspan="1">122</td>
                <td align="right" rowspan="1" colspan="1">135 (20)</td>
                <td align="right" rowspan="1" colspan="1">116</td>
                <td align="right" rowspan="1" colspan="1">132 (17)</td>
                <td align="right" rowspan="1" colspan="1">0.13</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Body temperature (&#xB0;C)</td>
                <td align="right" rowspan="1" colspan="1">235</td>
                <td align="right" rowspan="1" colspan="1">37.6 (1.1)</td>
                <td align="right" rowspan="1" colspan="1">120</td>
                <td align="right" rowspan="1" colspan="1">37.8 (1.1)</td>
                <td align="right" rowspan="1" colspan="1">115</td>
                <td align="right" rowspan="1" colspan="1">37.5 (1.0)</td>
                <td align="right" rowspan="1" colspan="1">0.011</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Pulse rate (per min)</td>
                <td align="right" rowspan="1" colspan="1">236</td>
                <td align="right" rowspan="1" colspan="1">85.1 (18.4)</td>
                <td align="right" rowspan="1" colspan="1">121</td>
                <td align="right" rowspan="1" colspan="1">85.7 (16.1)</td>
                <td align="right" rowspan="1" colspan="1">115</td>
                <td align="right" rowspan="1" colspan="1">84.6 (20.5)</td>
                <td align="right" rowspan="1" colspan="1">0.65</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Body mass index (kg/m2)</td>
                <td align="right" rowspan="1" colspan="1">184</td>
                <td align="right" rowspan="1" colspan="1">27.7 (4.9)</td>
                <td align="right" rowspan="1" colspan="1">94</td>
                <td align="right" rowspan="1" colspan="1">27.9 (5.6)</td>
                <td align="right" rowspan="1" colspan="1">90</td>
                <td align="right" rowspan="1" colspan="1">27.4 (4.0)</td>
                <td align="right" rowspan="1" colspan="1">0.47</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Laboratory tests at admission</italic>
</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">B-Hemoglobin (g/dL)</td>
                <td align="right" rowspan="1" colspan="1">240</td>
                <td align="right" rowspan="1" colspan="1">14.0 (1.5)</td>
                <td align="right" rowspan="1" colspan="1">123</td>
                <td align="right" rowspan="1" colspan="1">14.0 (1.6)</td>
                <td align="right" rowspan="1" colspan="1">117</td>
                <td align="right" rowspan="1" colspan="1">13.9 (1.4)</td>
                <td align="right" rowspan="1" colspan="1">0.76</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">C-reactive protein (mg/L), median (25th&#x2013;75th perc.)</td>
                <td align="right" rowspan="1" colspan="1">239</td>
                <td align="right" rowspan="1" colspan="1">50 (19&#x2013;112)</td>
                <td align="right" rowspan="1" colspan="1">123</td>
                <td align="right" rowspan="1" colspan="1">88 (42&#x2013;140)</td>
                <td align="right" rowspan="1" colspan="1">116</td>
                <td align="right" rowspan="1" colspan="1">27 (9&#x2013;67)</td>
                <td align="right" rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">P-Creatinine (&#x3BC;mol/L)</td>
                <td align="right" rowspan="1" colspan="1">237</td>
                <td align="right" rowspan="1" colspan="1">83.7 (47.1)</td>
                <td align="right" rowspan="1" colspan="1">123</td>
                <td align="right" rowspan="1" colspan="1">88.0 (56.1)</td>
                <td align="right" rowspan="1" colspan="1">114</td>
                <td align="right" rowspan="1" colspan="1">79.1 (34.5)</td>
                <td align="right" rowspan="1" colspan="1">0.15</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">B-Leukocytes (x 10^9/L)</td>
                <td align="right" rowspan="1" colspan="1">240</td>
                <td align="right" rowspan="1" colspan="1">8.5 (4.1)</td>
                <td align="right" rowspan="1" colspan="1">123</td>
                <td align="right" rowspan="1" colspan="1">9.7 (4.4)</td>
                <td align="right" rowspan="1" colspan="1">117</td>
                <td align="right" rowspan="1" colspan="1">7.3 (3.3)</td>
                <td align="right" rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<italic toggle="yes">During hospitalization</italic>
</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Length of stay (days), median (25th&#x2013;75th perc.)</td>
                <td align="right" rowspan="1" colspan="1">239</td>
                <td align="right" rowspan="1" colspan="1">6 (3&#x2013;12)</td>
                <td align="right" rowspan="1" colspan="1">124</td>
                <td align="right" rowspan="1" colspan="1">8.5 (4.5&#x2013;16)</td>
                <td align="right" rowspan="1" colspan="1">115</td>
                <td align="right" rowspan="1" colspan="1">4 (2&#x2013;7)</td>
                <td align="right" rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Ventilator treatment/intubation</td>
                <td align="right" rowspan="1" colspan="1">235</td>
                <td align="right" rowspan="1" colspan="1">31 (13)</td>
                <td align="right" rowspan="1" colspan="1">120</td>
                <td align="right" rowspan="1" colspan="1">25 (21)</td>
                <td align="right" rowspan="1" colspan="1">115</td>
                <td align="right" rowspan="1" colspan="1">6 (5)</td>
                <td align="right" rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">WHO severity rating</td>
                <td align="right" rowspan="1" colspan="1">241</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">124</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">117</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;3 No oxygen treatment</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">84 (35)</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">27 (22)</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">57 (49)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;4 Supplementary oxygen</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">116 (48)</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">66 (53)</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">50 (42)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;5&#x2013;7 High-flow oxygen/non-invasive or invasive ventilation/ECMO</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">41 (17)</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">31 (25)</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">10 (9)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Positive PCR-test for SARS-CoV2</td>
                <td align="right" rowspan="1" colspan="1">241</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">124</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">117</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">0.52</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;No</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">5 (2)</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">3 (2)</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">2 (2)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;Yes, before hospitalization</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">116 (48)</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">55 (44)</td>
                <td align="right" rowspan="1" colspan="1"/>
                <td align="right" rowspan="1" colspan="1">61 (52)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;Yes, during hospitalization</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">120 (50)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">66 (53)</td>
                <td align="right" rowspan="1" colspan="1">&#xA0;</td>
                <td align="right" rowspan="1" colspan="1">54 (46)</td>
                <td align="right" rowspan="1" colspan="1"/>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="t001fn001">
            <p>*t-test, chi-squared test or Fisher&#x2019;s exact test.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Among patients with Chest CT at 3 and 12 months (n = 126), 5 patients used steroids prior to hospitalization, and only an additional 2 patients were prescribed steroids during the hospital stay. Furthermore, 4 patients received interleukin-1 receptor antagonist (anakinra) and 1 received infusion with normal human IgG antibodies. In total, 8 of 126 patients were prescribed antibiotics for suspected secondary pulmonary or other infection. Information on oxygen use was not available at discharge. However, none of the patients used supplementary oxygen at the 12-month follow-up.</p>
      <sec id="sec011">
        <title>Chest CT severity scores</title>
        <p>Median CSS score (ranging from 0 to 12) for GGO decreased from 3 (25<sup>th</sup>&#x2013;75<sup>th</sup> percentile: 0&#x2013;12) at 3 months to 0.5 (0&#x2013;12) at 12 months (p&lt;0.001). A similar improvement was noted for mosaicism. Conversely, there was deterioration for parenchymal bands (p&lt;0.001) (<xref rid="pone.0302896.t002" ref-type="table">Table 2</xref>).</p>
        <table-wrap position="float" id="pone.0302896.t002">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302896.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>Chest CT severity scores at 3 months and comparison between scores at 3 and 12 months in those with follow-up chest CT.</title>
            <p>Median (range).</p>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302896.t002" id="pone.0302896.t002g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="2" colspan="1">Chest-CT severity score (0&#x2013;12 scale)</th>
                  <th align="center" rowspan="2" colspan="1">All with Chest-CT at 3 months (n = 242)</th>
                  <th align="center" colspan="2" rowspan="1">Subset with follow-up Chest-CT twice (n = 124)</th>
                  <th align="left" rowspan="1" colspan="1">&#xA0;</th>
                </tr>
                <tr>
                  <th align="right" rowspan="1" colspan="1">3 months</th>
                  <th align="right" rowspan="1" colspan="1">12 months</th>
                  <th align="center" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<xref rid="t002fn001" ref-type="table-fn">*</xref>
</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ground-glass opacities</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;12)</td>
                  <td align="right" rowspan="1" colspan="1">3 (0&#x2013;12)</td>
                  <td align="right" rowspan="1" colspan="1">0.5 (0&#x2013;12)</td>
                  <td align="right" rowspan="1" colspan="1">&lt;0.001</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Parenchymal bands</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;7)</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;7)</td>
                  <td align="right" rowspan="1" colspan="1">0.5 (0&#x2013;8)</td>
                  <td align="right" rowspan="1" colspan="1">0.003</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Mosaicism</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;8)</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;8)</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;7)</td>
                  <td align="right" rowspan="1" colspan="1">&lt;0.001</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Reticular pattern grade 1</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;8)</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;8)</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;6)</td>
                  <td align="right" rowspan="1" colspan="1">0.13</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Reticular pattern grade 2</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;12)</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;12)</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;7)</td>
                  <td align="right" rowspan="1" colspan="1">0.09</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Reticular pattern grade 3</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;4)</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;4)</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;0)</td>
                  <td align="right" rowspan="1" colspan="1">0.16</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Bronchiectasis</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;8)</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;8)</td>
                  <td align="right" rowspan="1" colspan="1">0 (0&#x2013;8)</td>
                  <td align="right" rowspan="1" colspan="1">0.094</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t002fn001">
              <p>*Wilcoxon sign rank test.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Transitions in individual CSS scores showed a similar trend (<xref rid="pone.0302896.g002" ref-type="fig">Fig 2</xref>).</p>
        <fig position="float" id="pone.0302896.g002">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302896.g002</object-id>
          <label>Fig 2</label>
          <caption>
            <title>Individual transfers of CT finding on ordinal 0&#x2013;12 scale (12 most severe), from 3 (3m) to 12 months (12m) after hospital admission for COVID-19.</title>
            <p>The lines are unweighted; hence, lines for several patients may be superimposed and do not reflect frequencies (n = 124). Red line connects median score at 3 and 12 months. The panels are: a. Ground-glass opacities, b. Parenchymal bands, c. Mosaicism, d. Reticular pattern grade 1.</p>
          </caption>
          <graphic xlink:href="pone.0302896.g002" position="float"/>
        </fig>
        <p>In analysis of changes between 3 and 12 months in the four most prevalent CT abnormalities, stratified according to initial WHO disease severity, there was an improvement across all severity categories for GGO, and in the most severe categories (4 and 5&#x2013;7) for mosaicism (<xref rid="pone.0302896.g003" ref-type="fig">Fig 3</xref>). For parenchymal bands, CSS scores increased between 3 and 12 months for those in the two least severe categories (3 and 4). <xref rid="pone.0302896.g004" ref-type="fig">Fig 4</xref> illustrates the individual changes within each disease severity stratum.</p>
        <fig position="float" id="pone.0302896.g003">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302896.g003</object-id>
          <label>Fig 3</label>
          <caption>
            <title>Change in CT findings on ordinal Chest CT severity (CSS), from 0 (none) to 12 (most severe) from 3 to 12 months after hospital admission for COVID-19, stratified according to WHO disease severity during the hospital stay (3 = No oxygen treatment, 4 = Supplementary oxygen, 5&#x2013;7 = High-flow oxygen/non-invasive or invasive ventilation/ECMO) (n = 124).</title>
            <p>The panels are: a. Ground-glass opacities, b. Parenchymal bands, c. Mosaicism, d. Reticular pattern grade 1.</p>
          </caption>
          <graphic xlink:href="pone.0302896.g003" position="float"/>
        </fig>
        <fig position="float" id="pone.0302896.g004">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302896.g004</object-id>
          <label>Fig 4</label>
          <caption>
            <title>Individual transfers of CT finding on ordinal 0&#x2013;12 scale (12 most severe), from 3 (3m) to 12 months (12m) after hospital admission for COVID-19, stratified according to WHO disease severity during the hospital stay (3 = No oxygen treatment, 4 = Supplementary oxygen, 5&#x2013;7 = High-flow oxygen/non-invasive or invasive ventilation/ECMO).</title>
            <p>The lines are unweighted; hence, lines for several patients may be superimposed and do not reflect frequencies (n = 124). The panels are: a. Ground-glass opacities, b. Parenchymal bands, c. Mosaicism, d. Reticular pattern grade 1.</p>
          </caption>
          <graphic xlink:href="pone.0302896.g004" position="float"/>
        </fig>
      </sec>
      <sec id="sec012">
        <title>Abbreviated chest CT severity scores</title>
        <p>The individual shifts in the aCSS scores (0&#x2013;3 range) from 3 to 12 months were larger for GGO than for the other three CT features (<xref rid="pone.0302896.g005" ref-type="fig">Fig 5</xref>).</p>
        <fig position="float" id="pone.0302896.g005">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302896.g005</object-id>
          <label>Fig 5</label>
          <caption>
            <title>Change in CT scores on abbreviated Chest CT severity (aCSS) scale from 3 (3m) to 12 months (12m).</title>
            <p>Scale categories are: 0 (none), 1 (mild), 2 (moderate), 3 (severe). Widths of flows represent frequencies. The panels are: a. Ground-glass opacities, b. Parenchymal bands, c. Mosaicism, d. Reticular pattern grade 1.</p>
          </caption>
          <graphic xlink:href="pone.0302896.g005" position="float"/>
        </fig>
        <p>In multivariable mixed effects ordinal regression aCSS scores, for GGO, the odds of being in a more severe aCSS category at 12 months were 0.11 (95%CI 00.05 to 0.21, p&lt;0.001) compared to 3 months after adjustment for age, sex and WHO severity (<xref rid="pone.0302896.t003" ref-type="table">Table 3</xref>). The odds of being in a more severe aCSS category were 7.16 (1.18 to 43.47, p = 0.032) for WHO severity category 5&#x2013;7 compared to category 3. The odds of being in a higher aCSS category were 4.80 (95%CI 1.33 to 17.6, p = 0.016) for age &#x2265;60 compared to &lt;60 years.</p>
        <table-wrap position="float" id="pone.0302896.t003">
          <object-id pub-id-type="doi">10.1371/journal.pone.0302896.t003</object-id>
          <label>Table 3</label>
          <caption>
            <title>Odd ratios for being in a higher category of abbreviated chest CT severity dimension score (0&#x2013;3 scale).</title>
            <p>Multivariable mixed effects ordinal regression analysis of radiological scores. (n = 248 CT scans; 124 patients).</p>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0302896.t003" id="pone.0302896.t003g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left" rowspan="1" colspan="1">&#xA0;</th>
                  <th align="left" rowspan="1" colspan="1">&#xA0;</th>
                  <th align="center" colspan="3" rowspan="1">Ground-glass opacities</th>
                  <th align="center" colspan="3" rowspan="1">Parenchymal bands</th>
                  <th align="center" colspan="3" rowspan="1">Mosaicism</th>
                  <th align="center" colspan="3" rowspan="1">Reticular pattern grade1</th>
                </tr>
                <tr>
                  <th align="left" rowspan="1" colspan="1">Covariate</th>
                  <th align="left" rowspan="1" colspan="1">n</th>
                  <th align="left" rowspan="1" colspan="1">Odds ratio</th>
                  <th align="left" rowspan="1" colspan="1">95% Conf. Interval</th>
                  <th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
</th>
                  <th align="left" rowspan="1" colspan="1">Odds ratio</th>
                  <th align="left" rowspan="1" colspan="1">95% Conf. Interval</th>
                  <th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
</th>
                  <th align="left" rowspan="1" colspan="1">Odds ratio</th>
                  <th align="left" rowspan="1" colspan="1">95% Conf. Interval</th>
                  <th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
</th>
                  <th align="left" rowspan="1" colspan="1">Odds ratio</th>
                  <th align="left" rowspan="1" colspan="1">95% Conf. Interval</th>
                  <th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Who severity rating, grouped</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;3* No oxygen</td>
                  <td align="right" rowspan="1" colspan="1">54</td>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;4 Oxygen</td>
                  <td align="right" rowspan="1" colspan="1">132</td>
                  <td align="right" rowspan="1" colspan="1">1.30</td>
                  <td align="left" rowspan="1" colspan="1">(0.28 to 6.01)</td>
                  <td align="right" rowspan="1" colspan="1">0.73</td>
                  <td align="right" rowspan="1" colspan="1">1.2</td>
                  <td align="left" rowspan="1" colspan="1">(0.32 to 4.51)</td>
                  <td align="right" rowspan="1" colspan="1">0.79</td>
                  <td align="right" rowspan="1" colspan="1">2.57</td>
                  <td align="left" rowspan="1" colspan="1">(0.71 to 9.27)</td>
                  <td align="right" rowspan="1" colspan="1">0.15</td>
                  <td align="right" rowspan="1" colspan="1">0.65</td>
                  <td align="left" rowspan="1" colspan="1">(0.08 to 5.20)</td>
                  <td align="right" rowspan="1" colspan="1">0.68</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;5&#x2013;7 High-flow /NIV/Ventilator/ECMO</td>
                  <td align="right" rowspan="1" colspan="1">62</td>
                  <td align="right" rowspan="1" colspan="1">7.16</td>
                  <td align="left" rowspan="1" colspan="1">(1.18 to 43.47)</td>
                  <td align="right" rowspan="1" colspan="1">0.032</td>
                  <td align="right" rowspan="1" colspan="1">22.9</td>
                  <td align="left" rowspan="1" colspan="1">(4.47 to 117.46)</td>
                  <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                  <td align="right" rowspan="1" colspan="1">3.69</td>
                  <td align="left" rowspan="1" colspan="1">(0.90 to 15.17)</td>
                  <td align="right" rowspan="1" colspan="1">0.071</td>
                  <td align="right" rowspan="1" colspan="1">6.42</td>
                  <td align="left" rowspan="1" colspan="1">(0.57 to 71.90)</td>
                  <td align="right" rowspan="1" colspan="1">0.13</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Age</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">&lt;60 years</td>
                  <td align="right" rowspan="1" colspan="1">116</td>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">&gt; = 60 years</td>
                  <td align="right" rowspan="1" colspan="1">132</td>
                  <td align="right" rowspan="1" colspan="1">4.80</td>
                  <td align="left" rowspan="1" colspan="1">(1.33 to 17.26)</td>
                  <td align="right" rowspan="1" colspan="1">0.016</td>
                  <td align="right" rowspan="1" colspan="1">1.98</td>
                  <td align="left" rowspan="1" colspan="1">(0.69 to 5.71)</td>
                  <td align="right" rowspan="1" colspan="1">0.21</td>
                  <td align="right" rowspan="1" colspan="1">0.36</td>
                  <td align="left" rowspan="1" colspan="1">(0.14 to 0.97)</td>
                  <td align="right" rowspan="1" colspan="1">0.043</td>
                  <td align="right" rowspan="1" colspan="1">3.86</td>
                  <td align="left" rowspan="1" colspan="1">(0.67 to 22.40)</td>
                  <td align="right" rowspan="1" colspan="1">0.13</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sex</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;Female*</td>
                  <td align="right" rowspan="1" colspan="1">92</td>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;Male</td>
                  <td align="right" rowspan="1" colspan="1">156</td>
                  <td align="right" rowspan="1" colspan="1">0.48</td>
                  <td align="left" rowspan="1" colspan="1">(0.13 to 1.73)</td>
                  <td align="right" rowspan="1" colspan="1">0.26</td>
                  <td align="right" rowspan="1" colspan="1">0.94</td>
                  <td align="left" rowspan="1" colspan="1">(0.32 to 2.76)</td>
                  <td align="right" rowspan="1" colspan="1">0.91</td>
                  <td align="right" rowspan="1" colspan="1">1.81</td>
                  <td align="left" rowspan="1" colspan="1">(0.65 to 5.01)</td>
                  <td align="right" rowspan="1" colspan="1">0.26</td>
                  <td align="right" rowspan="1" colspan="1">6.65</td>
                  <td align="left" rowspan="1" colspan="1">(1.02 to 43.43)</td>
                  <td align="right" rowspan="1" colspan="1">0.048</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Months after admission</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;3*</td>
                  <td align="right" rowspan="1" colspan="1">124</td>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="right" rowspan="1" colspan="1">1</td>
                  <td align="right" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">&#xA0;&#xA0;&#xA0;&#xA0;12</td>
                  <td align="right" rowspan="1" colspan="1">124</td>
                  <td align="right" rowspan="1" colspan="1">0.11</td>
                  <td align="left" rowspan="1" colspan="1">(0.05 to 0.21)</td>
                  <td align="right" rowspan="1" colspan="1">&lt;0.001</td>
                  <td align="right" rowspan="1" colspan="1">2.18</td>
                  <td align="left" rowspan="1" colspan="1">(1.16 to 4.10)</td>
                  <td align="right" rowspan="1" colspan="1">0.015</td>
                  <td align="right" rowspan="1" colspan="1">0.33</td>
                  <td align="left" rowspan="1" colspan="1">(0.16 to 0.66)</td>
                  <td align="right" rowspan="1" colspan="1">0.002</td>
                  <td align="right" rowspan="1" colspan="1">0.74</td>
                  <td align="left" rowspan="1" colspan="1">(0.30 to 1.81)</td>
                  <td align="right" rowspan="1" colspan="1">0.51</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">*Referent</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ICC subject</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.712 (0.573 to 0.820)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.592 (0.408 to 0.754)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.474 (0.268 to 0.690)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.882 (0.703 to 0.960)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">AIC</td>
                  <td align="left" rowspan="1" colspan="1">&#xA0;</td>
                  <td align="right" rowspan="1" colspan="1">580.1</td>
                  <td align="left" rowspan="1" colspan="1">&#xA0;</td>
                  <td align="left" rowspan="1" colspan="1">&#xA0;</td>
                  <td align="right" rowspan="1" colspan="1">413.8</td>
                  <td align="left" rowspan="1" colspan="1">&#xA0;</td>
                  <td align="left" rowspan="1" colspan="1">&#xA0;</td>
                  <td align="right" rowspan="1" colspan="1">413.5</td>
                  <td align="left" rowspan="1" colspan="1">&#xA0;</td>
                  <td align="left" rowspan="1" colspan="1">&#xA0;</td>
                  <td align="right" rowspan="1" colspan="1">280.7</td>
                  <td align="left" rowspan="1" colspan="1">&#xA0;</td>
                  <td align="left" rowspan="1" colspan="1">&#xA0;</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t003fn001">
              <p>ICC = intraclass correlation coefficient; AIC = Akaike&#x2019;s information criterion; NIV = non-invasive ventilation; ECMO = extra-corporeal membrane oxygenation.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>For parenchymal bands, there was a deterioration at 12 months compared to 3 months, OR 2.18 (95%CI 1.16 to 4,10, p = 0.015), and for WHO severity category 5&#x2013;7 compared to category 3, OR 22.90 (95%CI 4.47 to 117.46, p&lt;0.001). For mosaicism, there was an improvement at 12 compared to 3 months, with OR 0.33 (95%CI 0.16 to 0.66, p = 0.002).</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec013">
      <title>Discussion</title>
      <p>In this study, GGO and mosaicism decreased markedly from 3 to 12 months as assessed by changes in semi-quantitative ordinal CT scores, while parenchymal bands increased. The decrease in GGO was consistent across all severity groups. Multivariable regression models of abbreviated ordinal scores, confirmed these changes over time. GGO were also associated with initial COVID-19 severity and age&gt;60 years, and parenchymal bands were associated with initial disease severity.</p>
      <sec id="sec014">
        <title>Ground-glass opacities</title>
        <p>The finding of high CSS scores for lung GGO at 3 months with a decline in prevalence and CSS scores between 3 and 12 months after COVID-19 support previous reports using dichotomized data [<xref rid="pone.0302896.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0302896.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0302896.ref028" ref-type="bibr">28</xref>,<xref rid="pone.0302896.ref029" ref-type="bibr">29</xref>] or CT scores [<xref rid="pone.0302896.ref030" ref-type="bibr">30</xref>]. This was also supported in a multivariable model, after adjustment for relevant covariates. In a recent meta-analysis, the pooled prevalence of GGO after 1 year was 23.8% (range 2.4&#x2013;67.7%) with substantial heterogeneity between studies [<xref rid="pone.0302896.ref008" ref-type="bibr">8</xref>], reflecting variations in participant selection, severities, and study designs. The gradual resolution over time suggests that GGO is compatible with non-specific interstitial pneumonia patterns or post-organizing pneumonia that may resolve over time [<xref rid="pone.0302896.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0302896.ref031" ref-type="bibr">31</xref>].</p>
      </sec>
      <sec id="sec015">
        <title>Fibrotic-like changes</title>
        <p>In our study, grade1 reticular pattern and parenchymal bands were relatively common at 3 months, in line with findings in a meta-analysis with median follow-up of 3 months [<xref rid="pone.0302896.ref022" ref-type="bibr">22</xref>]. Early during the pandemic, parenchymal bands were a common finding after COVID-19 [<xref rid="pone.0302896.ref032" ref-type="bibr">32</xref>]. In some studies, such findings were not explicitly specified, but may have been included in a broader category termed &#x201C;fibrotic-like abnormalities&#x201D; [<xref rid="pone.0302896.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0302896.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0302896.ref030" ref-type="bibr">30</xref>,<xref rid="pone.0302896.ref033" ref-type="bibr">33</xref>], which varies across studies and may have led to overestimation of the prevalence [<xref rid="pone.0302896.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0302896.ref033" ref-type="bibr">33</xref>]. Parenchymal bands in thin-section chest CT may reflect pleuroparenchymal fibrosis. However, they often occur after asbestos exposure and are not commonly related to UIP (usual interstitial pneumonia) or other idiopathic interstitial lung diseases [<xref rid="pone.0302896.ref026" ref-type="bibr">26</xref>,<xref rid="pone.0302896.ref034" ref-type="bibr">34</xref>].</p>
        <p>In the present study, the severity of grade 1 reticular pattern remained unchanged from 3 to 12 months, while the severity scores for parenchymal bands increased. These findings are compatible with some previous reports, e.g., a systematic review with 1-year follow-up, including little change between 4&#x2013;7 months and 1-year follow-up [<xref rid="pone.0302896.ref007" ref-type="bibr">7</xref>]. A recent study reported fibrotic-like changes in 19% (32/169) at 4 months and persistence in 95% (18/19) after 16 months, but the number with longitudinal follow-up was small [<xref rid="pone.0302896.ref009" ref-type="bibr">9</xref>].</p>
        <p>CSS scores for parenchymal bands deteriorated for participants in the two least severe WHO categories (3 and 4), while no change was observed in the most severe category (5&#x2013;7). Deterioration in parenchymal bands over time raises concerns about the development of chronic lung conditions post-COVID-19, also in less severe cases. However, our findings also indicate that secondary pulmonary fibrosis was more common in patients with severe COVID-19.</p>
      </sec>
      <sec id="sec016">
        <title>Honeycombing/Traction bronciectasis</title>
        <p>In our study, grade 3 macrocystic reticular pattern, corresponding to honeycombing, was negligible and in agreement with previous reports at 12 months after COVID-19 infection [<xref rid="pone.0302896.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0302896.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0302896.ref035" ref-type="bibr">35</xref>]. Therefore, the risk of manifest UIP-like fibrosis after post COVID-19 seems small.</p>
        <p>We noted bronchial dilatation (traction bronchiectasis or traction bronchiolectasis) in only a few patients, with minimal observable changes between 3 and 12 months. This is in line with a low prevalence reported in other studies [<xref rid="pone.0302896.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0302896.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0302896.ref028" ref-type="bibr">28</xref>]. Bronchial dilatation may suggest fibrosis, but the relevance of the finding is unclear as it may be reversible following COVID-19 [<xref rid="pone.0302896.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0302896.ref037" ref-type="bibr">37</xref>].</p>
        <p>It is notable that pre-existing interstitial lung abnormalities, including honeycombing and bronchial dilatation, may be present in up to 9.7% of cases [<xref rid="pone.0302896.ref038" ref-type="bibr">38</xref>&#x2013;<xref rid="pone.0302896.ref040" ref-type="bibr">40</xref>], potentially predating the onset of COVID-19 infection. Therefore, an important limitation with follow-up studies after COVID-19 is the lack of CT studies prior to the infection for comparison.</p>
      </sec>
      <sec id="sec017">
        <title>Mosaicism</title>
        <p>Mosaicism on inspiratory scans [<xref rid="pone.0302896.ref026" ref-type="bibr">26</xref>] were relatively common at 3 months and declined between 3 and 12 months. We did not systematically use paired inspiratory and expiratory scans, but nine patients with mosaicism on inspiratory scans, had air trapping consistent with small airways disease on supplementary expiratory scans. Small airways disease is common in airways infections including COVID-19 [<xref rid="pone.0302896.ref041" ref-type="bibr">41</xref>,<xref rid="pone.0302896.ref042" ref-type="bibr">42</xref>], but air trapping is common also in healthy subjects without suspected small airways disease [<xref rid="pone.0302896.ref043" ref-type="bibr">43</xref>].</p>
      </sec>
      <sec id="sec018">
        <title>Association of CT abnormalities with disease severity</title>
        <p>In multivariable analysis of aCSS, we have shown that the extent of GGO was associated with initial COVID-19 severity and age&gt;60 years. Furthermore, parenchymal bands were associated with initial disease severity. Some studies have investigated associations with initial disease severity, with disparity between findings, and most studies are not adjusted for covariates. At about 1 year after COVID, no association with initial severity was shown for any chest CT feature [<xref rid="pone.0302896.ref013" ref-type="bibr">13</xref>], while another study reported an association for a global CT score and GGO, but not for other CT features at 12 months [<xref rid="pone.0302896.ref016" ref-type="bibr">16</xref>]. In multivariable analysis, increasing age was associated with an abnormal CT score [<xref rid="pone.0302896.ref016" ref-type="bibr">16</xref>], as in the present study, but disease severity was not examined. CT abnormality at 12 months were also associated with oxygen supply, and hospital length of stay, as markers of severity [<xref rid="pone.0302896.ref028" ref-type="bibr">28</xref>].</p>
        <p>A recent meta-analysis did not reveal any difference in residual CT abnormalities at 1 year between mild/moderate and severe patients [<xref rid="pone.0302896.ref007" ref-type="bibr">7</xref>]. In a meta-regression analysis of 14 studies, the percentage of people with severe or critical COVID-19 or relevant subject characteristics, such as age, sex, smoking status, hypertension or diabetes, were not associated with the 1-year prevalence of any residual lung abnormalities, i.e., an aggregate variable at study level [<xref rid="pone.0302896.ref008" ref-type="bibr">8</xref>].</p>
        <p>We have previously shown that there was an improvement in total lung capacity and diffusion capacity of the lungs for carbon monoxide (D<sub>LCO</sub>) from 3 to 12 month after hospitalization for COVID-19, and that there was little association of any fibrotic-like finding on chest-CT with D<sub>LCO</sub> or modified Medical Research Council dyspnea scores after 12 months in multivariable analysis [<xref rid="pone.0302896.ref017" ref-type="bibr">17</xref>]. Therefore, we have not repeated similar analyses with ordinal radiology scores.</p>
      </sec>
      <sec id="sec019">
        <title>Strengths and limitations</title>
        <p>The subjects in this study represent about 30% of surviving patients with COVID-19 in Norwegian hospitals during the recruitment period in 2020 (882 admitted with COVID-19 as main diagnosis, and 91 COVID-19-associated death in hospitals) [<xref rid="pone.0302896.ref044" ref-type="bibr">44</xref>]. The attrition rate in the study was low. Therefore, the study should be reasonably representative of survivors after hospitalization for COVID-19 during the first wave in Norway. The proportion of patients admitted to the ICU was lower than in some other reports, and the mortality and complication rate was low, probably reflecting that Norwegian hospitals did not have a severely constrained hospital capacity and admitted many less severely ill patients than in some other countries. The CT images were reviewed at one hospital, with a limited number of readers in consensus, which should ease standardization. The protocol included both prone and supine acquisitions, which enabled us to avoid misinterpreting random gravity-dependent atelectasis as GGO or reticular opacities. We used multilevel ordinal regression models that are suitable for such data [<xref rid="pone.0302896.ref020" ref-type="bibr">20</xref>], while it is not unusual that the analysis of such ordinal data is oversimplistic or inappropriate [<xref rid="pone.0302896.ref021" ref-type="bibr">21</xref>].</p>
        <p>The sample size was larger than many other longitudinal studies of CT after COVID-19, but still small. This limited the number of independent variables in multivariable analysis. Paired inspiratory and expiratory scans were not included in the CT protocol. All patients were hospitalized during the first wave of COVID-19 in 2020, when the genetic line B1 (Pangolin nomenclature) dominated in Norway with the exception of February 2020 [<xref rid="pone.0302896.ref045" ref-type="bibr">45</xref>]. Therefore, our sample might not be representative for the extent and severity of chest CT abnormalities for later corona virus variants, such as omicron, which lead to less extensive disease and a better prognosis [<xref rid="pone.0302896.ref046" ref-type="bibr">46</xref>].</p>
      </sec>
      <sec id="sec020">
        <title>Implications for clinical practice</title>
        <p>Understanding the long-term pulmonary consequences of COVID-19 is important for guiding clinical management and informing public health strategies. Consequently, longitudinal follow-up studies are essential to confirm or rule out irreversible lung damage following COVID-19. This study has also confirmed that the time to resolution for GGO is shorter than for some fibrotic-like abnormalities, as previously noted [<xref rid="pone.0302896.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0302896.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0302896.ref022" ref-type="bibr">22</xref>]. We have also identified disease severity and age as risk factors or prognostic indicators, suggesting that a closer eye on patients with severe disease and age &gt;60 might be sensible in follow-up after COVID-19. However, it is possible that many of the radiological abnormalities were detected in asymptomatic patients, but we have not presented data on this here.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec021">
      <title>Conclusion</title>
      <p>This study has shown high CSS for GGO at 3 months, but also parenchymal bands and mosaicism were common. Between 3 and 12 months, GGO and mosaicism decreased, while the presence of parenchymal bands increased, which were shown clearly by changes in the ordinal CSS and aCSS in multivariable models. Finally, those with severe COVID-19 had more persistent GGO and parenchymal bands.</p>
    </sec>
    <sec id="sec022" sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material id="pone.0302896.s001" position="float" content-type="local-data">
        <label>S1 File</label>
        <caption>
          <title>Details on chest CT protocol, and review and scoring of CT images.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0302896.s001.docx"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pone.0302896.ref001">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>Chung</surname><given-names>M</given-names></name>, <name><surname>Bernheim</surname><given-names>A</given-names></name>, <name><surname>Mei</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>N</given-names></name>, <name><surname>Huang</surname><given-names>M</given-names></name>, <name><surname>Zeng</surname><given-names>X</given-names></name>, <etal>et al</etal>. <article-title>CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)</article-title>. <source>Radiology</source>. <year>2020</year>;<volume>295</volume>(<issue>1</issue>):<fpage>202</fpage>&#x2013;<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.2020200230</pub-id>
<pub-id pub-id-type="pmid">32017661</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref002">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Jalaber</surname><given-names>C</given-names></name>, <name><surname>Lapotre</surname><given-names>T</given-names></name>, <name><surname>Morcet-Delattre</surname><given-names>T</given-names></name>, <name><surname>Ribet</surname><given-names>F</given-names></name>, <name><surname>Jouneau</surname><given-names>S</given-names></name>, <name><surname>Lederlin</surname><given-names>M</given-names></name>. <article-title>Chest CT in COVID-19 pneumonia: A review of current knowledge</article-title>. <source>Diagn Interv Imaging</source>. <year>2020</year>;<volume>101</volume>(<issue>7&#x2013;8</issue>):<fpage>431</fpage>&#x2013;<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.diii.2020.06.001</pub-id>
<pub-id pub-id-type="pmid">32571748</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref003">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>Z</given-names></name>, <name><surname>Lu</surname><given-names>Y</given-names></name>, <name><surname>Cao</surname><given-names>Q</given-names></name>, <name><surname>Qin</surname><given-names>L</given-names></name>, <name><surname>Pan</surname><given-names>Z</given-names></name>, <name><surname>Yan</surname><given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China</article-title>. <source>AJR Am J Roentgenol</source>. <year>2020</year>;<volume>215</volume>(<issue>1</issue>):<fpage>121</fpage>&#x2013;<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2214/AJR.20.22959</pub-id>
<pub-id pub-id-type="pmid">32174128</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref004">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>George</surname><given-names>PM</given-names></name>, <name><surname>Wells</surname><given-names>AU</given-names></name>, <name><surname>Jenkins</surname><given-names>RG</given-names></name>. <article-title>Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy</article-title>. <source>Lancet Respir Med</source>. <year>2020</year>;<volume>8</volume>(<issue>8</issue>):<fpage>807</fpage>&#x2013;<lpage>15</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30225-3</pub-id>
<pub-id pub-id-type="pmid">32422178</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref005">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Zou</surname><given-names>JN</given-names></name>, <name><surname>Sun</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>BR</given-names></name>, <name><surname>Zou</surname><given-names>Y</given-names></name>, <name><surname>Xu</surname><given-names>S</given-names></name>, <name><surname>Ding</surname><given-names>YJ</given-names></name>, <etal>et al</etal>. <article-title>The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT</article-title>. <source>PLoS One</source>. <year>2021</year>;<volume>16</volume>(<issue>3</issue>):<fpage>e0248957</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0248957</pub-id>
<pub-id pub-id-type="pmid">33755708</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref006">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>JH</given-names></name>, <name><surname>Yim</surname><given-names>JJ</given-names></name>, <name><surname>Park</surname><given-names>J</given-names></name>. <article-title>Pulmonary function and chest computed tomography abnormalities 6&#x2013;12 months after recovery from COVID-19: a systematic review and meta-analysis</article-title>. <source>Respir Res</source>. <year>2022</year>;<volume>23</volume>(<issue>1</issue>):<fpage>233</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12931-022-02163-x</pub-id>
<pub-id pub-id-type="pmid">36068582</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref007">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>Watanabe</surname><given-names>A</given-names></name>, <name><surname>So</surname><given-names>M</given-names></name>, <name><surname>Iwagami</surname><given-names>M</given-names></name>, <name><surname>Fukunaga</surname><given-names>K</given-names></name>, <name><surname>Takagi</surname><given-names>H</given-names></name>, <name><surname>Kabata</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>One-year follow-up CT findings in COVID-19 patients: A systematic review and meta-analysis</article-title>. <source>Respirology</source>. <year>2022</year>;<volume>27</volume>(<issue>8</issue>):<fpage>605</fpage>&#x2013;<lpage>16</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/resp.14311</pub-id>
<pub-id pub-id-type="pmid">35694728</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref008">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Bocchino</surname><given-names>M</given-names></name>, <name><surname>Rea</surname><given-names>G</given-names></name>, <name><surname>Capitelli</surname><given-names>L</given-names></name>, <name><surname>Lieto</surname><given-names>R</given-names></name>, <name><surname>Bruzzese</surname><given-names>D</given-names></name>. <article-title>Chest CT Lung Abnormalities 1 Year after COVID-19: A Systematic Review and Meta-Analysis</article-title>. <source>Radiology</source>. <year>2023</year>;<volume>308</volume>(<issue>1</issue>):<fpage>e230535</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.230535</pub-id>
<pub-id pub-id-type="pmid">37404150</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref009">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Soliman</surname><given-names>S</given-names></name>, <name><surname>Soliman</surname><given-names>H</given-names></name>, <name><surname>Creze</surname><given-names>M</given-names></name>, <name><surname>Brillet</surname><given-names>PY</given-names></name>, <name><surname>Montani</surname><given-names>D</given-names></name>, <name><surname>Savale</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Radiological pulmonary sequelae after COVID-19 and correlation with clinical and functional pulmonary evaluation: results of a prospective cohort</article-title>. <source>Eur Radiol</source>. <year>2023</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00330-023-10044-0</pub-id>
<pub-id pub-id-type="pmid">37572192</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref010">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Bocchino</surname><given-names>M</given-names></name>, <name><surname>Lieto</surname><given-names>R</given-names></name>, <name><surname>Romano</surname><given-names>F</given-names></name>, <name><surname>Sica</surname><given-names>G</given-names></name>, <name><surname>Bocchini</surname><given-names>G</given-names></name>, <name><surname>Muto</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Chest CT-based Assessment of 1-year Outcomes after Moderate COVID-19 Pneumonia</article-title>. <source>Radiology</source>. <year>2022</year>;<volume>305</volume>(<issue>2</issue>):<fpage>479</fpage>&#x2013;<lpage>85</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.220019</pub-id>
<pub-id pub-id-type="pmid">35536134</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref011">
        <label>11</label>
        <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>L</given-names></name>, <name><surname>Yao</surname><given-names>Q</given-names></name>, <name><surname>Gu</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Ren</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study</article-title>. <source>Lancet</source>. <year>2021</year>;<volume>398</volume>(<issue>10302</issue>):<fpage>747</fpage>&#x2013;<lpage>58</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(21)01755-4</pub-id>
<pub-id pub-id-type="pmid">34454673</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref012">
        <label>12</label>
        <mixed-citation publication-type="journal"><name><surname>Pan</surname><given-names>F</given-names></name>, <name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Liang</surname><given-names>B</given-names></name>, <name><surname>Ye</surname><given-names>T</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Chest CT Patterns from Diagnosis to 1 Year of Follow-up in Patients with COVID-19</article-title>. <source>Radiology</source>. <year>2022</year>;<volume>302</volume>(<issue>3</issue>):<fpage>709</fpage>&#x2013;<lpage>19</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.2021211199</pub-id>
<pub-id pub-id-type="pmid">34609153</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref013">
        <label>13</label>
        <mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>F</given-names></name>, <name><surname>Tao</surname><given-names>M</given-names></name>, <name><surname>Shang</surname><given-names>L</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Pan</surname><given-names>G</given-names></name>, <name><surname>Jin</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Assessment of Sequelae of COVID-19 Nearly 1 Year After Diagnosis</article-title>. <source>Front Med (Lausanne)</source>. <year>2021</year>;<volume>8</volume>:<fpage>717194</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fmed.2021.717194</pub-id>
<pub-id pub-id-type="pmid">34888318</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref014">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Sarioglu</surname><given-names>N</given-names></name>, <name><surname>Aksu</surname><given-names>GD</given-names></name>, <name><surname>Coban</surname><given-names>H</given-names></name>, <name><surname>Bulbul</surname><given-names>E</given-names></name>, <name><surname>Demirpolat</surname><given-names>G</given-names></name>, <name><surname>Arslan</surname><given-names>AT</given-names></name>, <etal>et al</etal>. <article-title>Clinical and radiological outcomes of longCOVID: Is the post-COVID fibrosis common?</article-title>
<source>Tuberk Toraks</source>. <year>2023</year>;<volume>71</volume>(<issue>1</issue>):<fpage>48</fpage>&#x2013;<lpage>57</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5578/tt.20239907</pub-id>
<pub-id pub-id-type="pmid">36912409</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref015">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>Luger</surname><given-names>AK</given-names></name>, <name><surname>Sonnweber</surname><given-names>T</given-names></name>, <name><surname>Gruber</surname><given-names>L</given-names></name>, <name><surname>Schwabl</surname><given-names>C</given-names></name>, <name><surname>Cima</surname><given-names>K</given-names></name>, <name><surname>Tymoszuk</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Chest CT of Lung Injury 1 Year after COVID-19 Pneumonia: The CovILD Study</article-title>. <source>Radiology</source>. <year>2022</year>;<volume>304</volume>(<issue>2</issue>):<fpage>462</fpage>&#x2013;<lpage>70</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.211670</pub-id>
<pub-id pub-id-type="pmid">35348379</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref016">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Yang</surname><given-names>C</given-names></name>, <name><surname>An</surname><given-names>X</given-names></name>, <name><surname>Xiong</surname><given-names>Y</given-names></name>, <name><surname>Shang</surname><given-names>Y</given-names></name>, <name><surname>He</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Follow-up study on COVID-19 survivors one year after discharge from hospital</article-title>. <source>Int J Infect Dis</source>. <year>2021</year>;<volume>112</volume>:<fpage>173</fpage>&#x2013;<lpage>82</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ijid.2021.09.017</pub-id>
<pub-id pub-id-type="pmid">34520845</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref017">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Lerum</surname><given-names>TV</given-names></name>, <name><surname>Meltzer</surname><given-names>C</given-names></name>, <name><surname>Rodriguez</surname><given-names>JR</given-names></name>, <name><surname>Aalokken</surname><given-names>TM</given-names></name>, <name><surname>Bronstad</surname><given-names>E</given-names></name>, <name><surname>Aarli</surname><given-names>BB</given-names></name>, <etal>et al</etal>. <article-title>A prospective study of pulmonary outcomes and chest computed tomography in the first year after COVID-19</article-title>. <source>ERJ Open Res</source>. <year>2023</year>;<volume>9</volume>(<issue>2</issue>):<fpage>00575</fpage>&#x2013;<lpage>2022</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1183/23120541.00575-2022</pub-id>
<pub-id pub-id-type="pmid">36915802</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref018">
        <label>18</label>
        <mixed-citation publication-type="journal"><name><surname>Dilek</surname><given-names>O</given-names></name>, <name><surname>Demirel</surname><given-names>E</given-names></name>, <name><surname>Akkaya</surname><given-names>H</given-names></name>, <name><surname>Belibagli</surname><given-names>MC</given-names></name>, <name><surname>Soker</surname><given-names>G</given-names></name>, <name><surname>Gulek</surname><given-names>B</given-names></name>. <article-title>Different chest CT scoring systems in patients with COVID-19: could baseline CT be a helpful tool in predicting survival in patients with matched ages and co-morbid conditions?</article-title>
<source>Acta Radiol</source>. <year>2022</year>;<volume>63</volume>(<issue>5</issue>):<fpage>615</fpage>&#x2013;<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/02841851211006316</pub-id>
<pub-id pub-id-type="pmid">33845610</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref019">
        <label>19</label>
        <mixed-citation publication-type="journal"><name><surname>Elmokadem</surname><given-names>AH</given-names></name>, <name><surname>Mounir</surname><given-names>AM</given-names></name>, <name><surname>Ramadan</surname><given-names>ZA</given-names></name>, <name><surname>Elsedeiq</surname><given-names>M</given-names></name>, <name><surname>Saleh</surname><given-names>GA</given-names></name>. <article-title>Comparison of chest CT severity scoring systems for COVID-19</article-title>. <source>Eur Radiol</source>. <year>2022</year>;<volume>32</volume>(<issue>5</issue>):<fpage>3501</fpage>&#x2013;<lpage>12</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00330-021-08432-5</pub-id>
<pub-id pub-id-type="pmid">35031841</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref020">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Saffari</surname><given-names>SE</given-names></name>, <name><surname>Love</surname><given-names>A</given-names></name>, <name><surname>Fredrikson</surname><given-names>M</given-names></name>, <name><surname>Smedby</surname><given-names>O</given-names></name>. <article-title>Regression models for analyzing radiological visual grading studies&#x2014;an empirical comparison</article-title>. <source>BMC Med Imaging</source>. <year>2015</year>;<volume>15</volume>:<fpage>49</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12880-015-0083-y</pub-id>
<pub-id pub-id-type="pmid">26515510</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref021">
        <label>21</label>
        <mixed-citation publication-type="journal"><name><surname>Keeble</surname><given-names>C</given-names></name>, <name><surname>Baxter</surname><given-names>PD</given-names></name>, <name><surname>Gislason-Lee</surname><given-names>AJ</given-names></name>, <name><surname>Treadgold</surname><given-names>LA</given-names></name>, <name><surname>Davies</surname><given-names>AG</given-names></name>. <article-title>Methods for the analysis of ordinal response data in medical image quality assessment</article-title>. <source>Br J Radiol</source>. <year>2016</year>;<volume>89</volume>(<issue>1063</issue>):<fpage>20160094</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1259/bjr.20160094</pub-id>
<pub-id pub-id-type="pmid">26975497</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref022">
        <label>22</label>
        <mixed-citation publication-type="journal"><name><surname>Fabbri</surname><given-names>L</given-names></name>, <name><surname>Moss</surname><given-names>S</given-names></name>, <name><surname>Khan</surname><given-names>FA</given-names></name>, <name><surname>Chi</surname><given-names>W</given-names></name>, <name><surname>Xia</surname><given-names>J</given-names></name>, <name><surname>Robinson</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis</article-title>. <source>Thorax</source>. <year>2023</year>;<volume>78</volume>(<issue>2</issue>):<fpage>191</fpage>&#x2013;<lpage>201</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/thoraxjnl-2021-218275</pub-id>
<pub-id pub-id-type="pmid">35338102</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref023">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>Lerum</surname><given-names>TV</given-names></name>, <name><surname>Aalokken</surname><given-names>TM</given-names></name>, <name><surname>Bronstad</surname><given-names>E</given-names></name>, <name><surname>Aarli</surname><given-names>B</given-names></name>, <name><surname>Ikdahl</surname><given-names>E</given-names></name>, <name><surname>Lund</surname><given-names>KMA</given-names></name>, <etal>et al</etal>. <article-title>Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19</article-title>. <source>Eur Respir J</source>. <year>2021</year>;<volume>57</volume>(<issue>4</issue>):<fpage>2003448</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1183/13993003.03448&#x2013;2020</pub-id><pub-id pub-id-type="pmid">33303540</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref024">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Charlson</surname><given-names>ME</given-names></name>, <name><surname>Pompei</surname><given-names>P</given-names></name>, <name><surname>Ales</surname><given-names>KL</given-names></name>, <name><surname>MacKenzie</surname><given-names>CR</given-names></name>. <article-title>A new method of classifying prognostic comorbidity in longitudinal studies: development and validation</article-title>. <source>J Chronic Dis</source>. <year>1987</year>;<volume>40</volume>(<issue>5</issue>):<fpage>373</fpage>&#x2013;<lpage>83</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0021-9681(87)90171-8</pub-id>
<pub-id pub-id-type="pmid">3558716</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref025">
        <label>25</label>
        <mixed-citation publication-type="book"><source>WHO R&amp;D Blueprint novel CoronavirusCOVID-19 Therapeutic Trial Synopsis Geneva</source>, <publisher-loc>Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2020</year> [Available from: <ext-link xlink:href="https://cdn.who.int/media/docs/default-source/blue-print/covid-19-therapeutic-trial-synopsis.pdf" ext-link-type="uri">https://cdn.who.int/media/docs/default-source/blue-print/covid-19-therapeutic-trial-synopsis.pdf</ext-link>.</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref026">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Hansell</surname><given-names>DM</given-names></name>, <name><surname>Bankier</surname><given-names>AA</given-names></name>, <name><surname>MacMahon</surname><given-names>H</given-names></name>, <name><surname>McLoud</surname><given-names>TC</given-names></name>, <name><surname>Muller</surname><given-names>NL</given-names></name>, <name><surname>Remy</surname><given-names>J</given-names></name>. <article-title>Fleischner Society: glossary of terms for thoracic imaging</article-title>. <source>Radiology</source>. <year>2008</year>;<volume>246</volume>(<issue>3</issue>):<fpage>697</fpage>&#x2013;<lpage>722</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.2462070712</pub-id>
<pub-id pub-id-type="pmid">18195376</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref027">
        <label>27</label>
        <mixed-citation publication-type="journal"><name><surname>Soyseth</surname><given-names>V</given-names></name>, <name><surname>Aalokken</surname><given-names>TM</given-names></name>, <name><surname>Mynarek</surname><given-names>G</given-names></name>, <name><surname>Naalsund</surname><given-names>A</given-names></name>, <name><surname>Strom</surname><given-names>EH</given-names></name>, <name><surname>Scott</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Diagnosis of biopsy verified usual interstitial pneumonia by computed tomography</article-title>. <source>Respir Med</source>. <year>2015</year>;<volume>109</volume>(<issue>7</issue>):<fpage>897</fpage>&#x2013;<lpage>903</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.rmed.2015.05.008</pub-id>
<pub-id pub-id-type="pmid">26028484</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref028">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Zhou</surname><given-names>Y</given-names></name>, <name><surname>Yu</surname><given-names>H</given-names></name>, <name><surname>Li</surname><given-names>R</given-names></name>, <name><surname>Zhan</surname><given-names>Q</given-names></name>, <etal>et al</etal>. <article-title>3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study</article-title>. <source>Lancet Respir Med</source>. <year>2021</year>;<volume>9</volume>(<issue>7</issue>):<fpage>747</fpage>&#x2013;<lpage>54</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2213-2600(21)00174-0</pub-id>
<pub-id pub-id-type="pmid">33964245</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref029">
        <label>29</label>
        <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Han</surname><given-names>X</given-names></name>, <name><surname>Huang</surname><given-names>J</given-names></name>, <name><surname>Alwalid</surname><given-names>O</given-names></name>, <name><surname>Jia</surname><given-names>X</given-names></name>, <name><surname>Yuan</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Follow-up study of pulmonary sequelae in discharged COVID-19 patients with diabetes or secondary hyperglycemia</article-title>. <source>Eur J Radiol</source>. <year>2021</year>;<volume>144</volume>:<fpage>109997</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ejrad.2021.109997</pub-id>
<pub-id pub-id-type="pmid">34634534</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref030">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>X</given-names></name>, <name><surname>Fan</surname><given-names>Y</given-names></name>, <name><surname>Alwalid</surname><given-names>O</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Jia</surname><given-names>X</given-names></name>, <name><surname>Zheng</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19</article-title>. <source>Radiology</source>. <year>2021</year>;<volume>301</volume>(<issue>3</issue>):<fpage>E438</fpage>&#x2013;<lpage>E40</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.2021210972</pub-id>
<pub-id pub-id-type="pmid">34313470</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref031">
        <label>31</label>
        <mixed-citation publication-type="journal"><name><surname>Parraga</surname><given-names>G</given-names></name>, <name><surname>Svenningsen</surname><given-names>S</given-names></name>. <article-title>Chest CT Findings 1 Year after COVID-19: Another Piece of the Post-Pandemic Puzzle</article-title>. <source>Radiology</source>. <year>2023</year>;<volume>308</volume>(<issue>1</issue>):<fpage>e231502</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.231502</pub-id>
<pub-id pub-id-type="pmid">37404151</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref032">
        <label>32</label>
        <mixed-citation publication-type="journal"><name><surname>Sanchez-Ramirez</surname><given-names>DC</given-names></name>, <name><surname>Normand</surname><given-names>K</given-names></name>, <name><surname>Zhaoyun</surname><given-names>Y</given-names></name>, <name><surname>Torres-Castro</surname><given-names>R</given-names></name>. <article-title>Long-Term Impact of COVID-19: A Systematic Review of the Literature and Meta-Analysis</article-title>. <source>Biomedicines</source>. <year>2021</year>;<volume>9</volume>(<issue>8</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/biomedicines9080900</pub-id>
<pub-id pub-id-type="pmid">34440104</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref033">
        <label>33</label>
        <mixed-citation publication-type="journal"><name><surname>Kanne</surname><given-names>JP</given-names></name>, <name><surname>Little</surname><given-names>BP</given-names></name>, <name><surname>Schulte</surname><given-names>JJ</given-names></name>, <name><surname>Haramati</surname><given-names>A</given-names></name>, <name><surname>Haramati</surname><given-names>LB</given-names></name>. <article-title>Long-term Lung Abnormalities Associated with COVID-19 Pneumonia</article-title>. <source>Radiology</source>. <year>2023</year>;<volume>306</volume>(<issue>2</issue>):<fpage>e221806</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.221806</pub-id>
<pub-id pub-id-type="pmid">36040336</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref034">
        <label>34</label>
        <mixed-citation publication-type="journal"><name><surname>Akira</surname><given-names>M</given-names></name>, <name><surname>Yamamoto</surname><given-names>S</given-names></name>, <name><surname>Inoue</surname><given-names>Y</given-names></name>, <name><surname>Sakatani</surname><given-names>M</given-names></name>. <article-title>High-resolution CT of asbestosis and idiopathic pulmonary fibrosis</article-title>. <source>AJR Am J Roentgenol</source>. <year>2003</year>;<volume>181</volume>(<issue>1</issue>):<fpage>163</fpage>&#x2013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2214/ajr.181.1.1810163</pub-id>
<pub-id pub-id-type="pmid">12818850</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref035">
        <label>35</label>
        <mixed-citation publication-type="journal"><name><surname>Faverio</surname><given-names>P</given-names></name>, <name><surname>Luppi</surname><given-names>F</given-names></name>, <name><surname>Rebora</surname><given-names>P</given-names></name>, <name><surname>D&#x2019;Andrea</surname><given-names>G</given-names></name>, <name><surname>Stainer</surname><given-names>A</given-names></name>, <name><surname>Busnelli</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study</article-title>. <source>Respir Res</source>. <year>2022</year>;<volume>23</volume>(<issue>1</issue>):<fpage>65</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12931-022-01994-y</pub-id>
<pub-id pub-id-type="pmid">35313890</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref036">
        <label>36</label>
        <mixed-citation publication-type="journal"><name><surname>Ye</surname><given-names>Z</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Huang</surname><given-names>Z</given-names></name>, <name><surname>Song</surname><given-names>B</given-names></name>. <article-title>Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review</article-title>. <source>Eur Radiol</source>. <year>2020</year>;<volume>30</volume>(<issue>8</issue>):<fpage>4381</fpage>&#x2013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00330-020-06801-0</pub-id>
<pub-id pub-id-type="pmid">32193638</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref037">
        <label>37</label>
        <mixed-citation publication-type="journal"><name><surname>Hanley</surname><given-names>B</given-names></name>, <name><surname>Lucas</surname><given-names>SB</given-names></name>, <name><surname>Youd</surname><given-names>E</given-names></name>, <name><surname>Swift</surname><given-names>B</given-names></name>, <name><surname>Osborn</surname><given-names>M</given-names></name>. <article-title>Autopsy in suspected COVID-19 cases</article-title>. <source>J Clin Pathol</source>. <year>2020</year>;<volume>73</volume>(<issue>5</issue>):<fpage>239</fpage>&#x2013;<lpage>42</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/jclinpath-2020-206522</pub-id>
<pub-id pub-id-type="pmid">32198191</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref038">
        <label>38</label>
        <mixed-citation publication-type="journal"><name><surname>Hatabu</surname><given-names>H</given-names></name>, <name><surname>Hunninghake</surname><given-names>GM</given-names></name>, <name><surname>Lynch</surname><given-names>DA</given-names></name>. <article-title>Interstitial Lung Abnormality: Recognition and Perspectives</article-title>. <source>Radiology</source>. <year>2019</year>;<volume>291</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>3</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.2018181684</pub-id>
<pub-id pub-id-type="pmid">30561274</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref039">
        <label>39</label>
        <mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>GY</given-names></name>, <name><surname>Lynch</surname><given-names>D</given-names></name>, <name><surname>Chawla</surname><given-names>A</given-names></name>, <name><surname>Garg</surname><given-names>K</given-names></name>, <name><surname>Tammemagi</surname><given-names>MC</given-names></name>, <name><surname>Sahin</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate</article-title>. <source>Radiology</source>. <year>2013</year>;<volume>268</volume>(<issue>2</issue>):<fpage>563</fpage>&#x2013;<lpage>71</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.13120816</pub-id>
<pub-id pub-id-type="pmid">23513242</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref040">
        <label>40</label>
        <mixed-citation publication-type="journal"><name><surname>Hatabu</surname><given-names>H</given-names></name>, <name><surname>Hunninghake</surname><given-names>GM</given-names></name>, <name><surname>Richeldi</surname><given-names>L</given-names></name>, <name><surname>Brown</surname><given-names>KK</given-names></name>, <name><surname>Wells</surname><given-names>AU</given-names></name>, <name><surname>Remy-Jardin</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society</article-title>. <source>Lancet Respir Med</source>. <year>2020</year>;<volume>8</volume>(<issue>7</issue>):<fpage>726</fpage>&#x2013;<lpage>37</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30168-5</pub-id>
<pub-id pub-id-type="pmid">32649920</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref041">
        <label>41</label>
        <mixed-citation publication-type="journal"><name><surname>Franquet</surname><given-names>T</given-names></name>, <name><surname>Gimenez</surname><given-names>A</given-names></name>, <name><surname>Ketai</surname><given-names>L</given-names></name>, <name><surname>Mazzini</surname><given-names>S</given-names></name>, <name><surname>Rial</surname><given-names>A</given-names></name>, <name><surname>Pomar</surname><given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT</article-title>. <source>Eur Radiol</source>. <year>2022</year>;<volume>32</volume>(<issue>7</issue>):<fpage>4427</fpage>&#x2013;<lpage>36</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00330-022-08580-2</pub-id>
<pub-id pub-id-type="pmid">35226158</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref042">
        <label>42</label>
        <mixed-citation publication-type="journal"><name><surname>Cho</surname><given-names>JL</given-names></name>, <name><surname>Villacreses</surname><given-names>R</given-names></name>, <name><surname>Nagpal</surname><given-names>P</given-names></name>, <name><surname>Guo</surname><given-names>J</given-names></name>, <name><surname>Pezzulo</surname><given-names>AA</given-names></name>, <name><surname>Thurman</surname><given-names>AL</given-names></name>, <etal>et al</etal>. <article-title>Quantitative Chest CT Assessment of Small Airways Disease in Post-Acute SARS-CoV-2 Infection</article-title>. <source>Radiology</source>. <year>2022</year>;<volume>304</volume>(<issue>1</issue>):<fpage>185</fpage>&#x2013;<lpage>92</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.212170</pub-id>
<pub-id pub-id-type="pmid">35289657</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref043">
        <label>43</label>
        <mixed-citation publication-type="journal"><name><surname>Tanaka</surname><given-names>N</given-names></name>, <name><surname>Matsumoto</surname><given-names>T</given-names></name>, <name><surname>Miura</surname><given-names>G</given-names></name>, <name><surname>Emoto</surname><given-names>T</given-names></name>, <name><surname>Matsunaga</surname><given-names>N</given-names></name>, <name><surname>Ueda</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Air trapping at CT: high prevalence in asymptomatic subjects with normal pulmonary function</article-title>. <source>Radiology</source>. <year>2003</year>;<volume>227</volume>(<issue>3</issue>):<fpage>776</fpage>&#x2013;<lpage>85</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.2273020352</pub-id>
<pub-id pub-id-type="pmid">12702825</pub-id>
</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref044">
        <label>44</label>
        <mixed-citation publication-type="other">COVID-19 Dagsrapport onsdag 3. juni 2020 Oslo, Norway: National Institute of Public Health; 2020 [updated 02.11.2023. Available from: <ext-link xlink:href="https://www.fhi.no/contentassets/e110607a67df46cbba8e30a443264a73/vedlegg/2020.06.03-dagsrapport-norge-covid-19.pdf" ext-link-type="uri">https://www.fhi.no/contentassets/e110607a67df46cbba8e30a443264a73/vedlegg/2020.06.03-dagsrapport-norge-covid-19.pdf</ext-link>.</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref045">
        <label>45</label>
        <mixed-citation publication-type="other">Ukerapport uke 48, onsdag 2.desember 2020 Oslo, Norway: National Institute of Public Health; 2020 [updated 02.11.2023. Available from: <ext-link xlink:href="https://www.fhi.no/contentassets/8a971e7b0a3c4a06bdbf381ab52e6157/vedlegg/4.-andre-halvar-2020/2020.12.02-ukerapport-uke-48-covid-19.pdf" ext-link-type="uri">https://www.fhi.no/contentassets/8a971e7b0a3c4a06bdbf381ab52e6157/vedlegg/4.-andre-halvar&#x2014;2020/2020.12.02-ukerapport-uke-48-covid-19.pdf</ext-link>.</mixed-citation>
      </ref>
      <ref id="pone.0302896.ref046">
        <label>46</label>
        <mixed-citation publication-type="journal"><name><surname>Tsakok</surname><given-names>MT</given-names></name>, <name><surname>Watson</surname><given-names>RA</given-names></name>, <name><surname>Saujani</surname><given-names>SJ</given-names></name>, <name><surname>Kong</surname><given-names>M</given-names></name>, <name><surname>Xie</surname><given-names>C</given-names></name>, <name><surname>Peschl</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection</article-title>. <source>Radiology</source>. <year>2023</year>;<volume>306</volume>(<issue>1</issue>):<fpage>261</fpage>&#x2013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiol.220533</pub-id>
<pub-id pub-id-type="pmid">35727150</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="aggregated-review-documents" id="pone.0302896.r001" specific-use="decision-letter">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pone.0302896.r001</article-id>
      <title-group>
        <article-title>Decision Letter 0</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Julie</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>&#xA9; 2024 Julie Zhu</copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>Julie Zhu</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0302896" id="rel-obj001" related-article-type="reviewed-article"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>0</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">29 Jan 2024</named-content>
</p>
      <p><!-- <div> -->PONE-D-23-42962<!-- </div> --><!-- <div> -->CT abnormalities 3 and 12 months after hospitalization for COVID-19 and association with disease severity: a prospective cohort study<!-- </div> --><!-- <div> -->PLOS ONE</p>
      <p>Dear Dr. Stavem,</p>
      <p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#x2019;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
      <p>Please submit your revised manuscript by Mar 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at&#xA0;<email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
      <p>Please include the following items when submitting your revised manuscript:<!-- </div> --><list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list><!-- <div> -->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
      <p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p>
      <p>We look forward to receiving your revised manuscript.</p>
      <p>Kind regards,</p>
      <p>Julie Zhu</p>
      <p>Academic Editor</p>
      <p>PLOS ONE</p>
      <p>Journal Requirements:</p>
      <p>When submitting your revision, we need you to address these additional requirements.</p>
      <p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at&#xA0;</p>
      <p><ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and&#xA0;</p>
      <p>
<ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>
</p>
      <p>2. Thank you for stating the following in the Competing Interests section:&#xA0;</p>
      <p>"Haseem Ashraf reports grant from Boehringer-Ingelheim, Norway. Knut Stavem reports personal fees from UCB Pharma and MSD Norway, unrelated to this study."</p>
      <p>We note that you received funding from a commercial source: UCB Pharma and MSD Norway</p>
      <p>Please provide an amended Competing Interests Statement that explicitly states this commercial funder, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc.&#xA0;</p>
      <p>Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: ""This does not alter our adherence to PLOS ONE policies on sharing data and materials.&#x201D; (as detailed online in our guide for authors <ext-link xlink:href="http://journals.plos.org/plosone/s/competing-interests" ext-link-type="uri">http://journals.plos.org/plosone/s/competing-interests</ext-link>).&#xA0; If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.&#xA0;</p>
      <p>Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf.</p>
      <p>3. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere:</p>
      <p>"Yes. The cohort has been presented before, including follow up at 3 and 12 months.&#xA0;</p>
      <p>Crude prevalence of radiology findings has been presented along with lung function/gas diffusion findings, but these prevalences are not presented/repeated in the present&#xA0; publication. The paper focuses on ordinal scores of CT images, including comprehensive analysis of these scores."</p>
      <p>Please clarify whether this [conference proceeding or publication] was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript.</p>
      <p>4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: <ext-link xlink:href="http://journals.plos.org/plosone/s/supporting-information.&#xA0;" ext-link-type="uri">http://journals.plos.org/plosone/s/supporting-information.&#xA0;</ext-link></p>
      <p>5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article&#x2019;s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
      <p>
<bold>Additonal Editor Comments:</bold>
</p>
      <p>Thank you for submitting this important manuscript. Would appreciate your&#xA0;review, revision&#xA0;and resubmission&#xA0;according to reviewers' comments.</p>
      <p>Reviewers' comments:</p>
      <p>Reviewer's Responses to Questions</p>
      <p>
<!-- <font color="black"> -->
<bold>Comments to the Author</bold>
</p>
      <p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
      <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. <!-- </font> --></p>
      <p>Reviewer #1:&#xA0;Yes</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->2. Has the statistical analysis been performed appropriately and rigorously? <!-- </font> --></p>
      <p>Reviewer #1:&#xA0;Yes</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
      <p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#x2014;e.g. participant privacy or use of data from a third party&#x2014;those must be specified.<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;No</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
      <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;Yes</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->5. Review Comments to the Author</p>
      <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;Referees comments on CT abnormalities 3 and 12 months after hospitalization for COVID-19 and association with disease severity: a prospective cohort study</p>
      <p>PONE-D-23-42962</p>
      <p>Studies assessing the long term effects of Covid-19 is of huge importance. The virus was associated to intense changes in lung function, and CT-imaging did during the acute phase showed profound pathology. The resolution of CT-changes is of interest but must of course be put in context of the physiological associated effects. Lung function oxygenation, and capacity to regain pre-infectious working capacity is of outmost importance.</p>
      <p>The present study from Norway presents results from 3 and 12 months CT follow-up of a huge groups of Covid-19 patients. It shows that ground-glass opacities (GGO) and mosaicism decreased, while parenchymal bands increased from 3 to 12 months. Persistent GGO were associated with initial COVID-19 severity and age &#x2265;60 years. It provides however no information around lung function; patients assessment of breathing and work capacity or physiological measures of the lung function.</p>
      <p>The CT-findings and analysis in relation to patients&#x2019; demographics, comorbidities, on acute phase disease severity is done in a statistically sophisticated and reasonable fashion. The main weakness is the lack of information around the association to lung function and even more important as well as patients assessed outcome.</p>
      <p>Some questions that I see could be of value to clarify;</p>
      <p>How many of the patients were provided steroids, and dose of steroids if given.</p>
      <p>How many of patients experienced any kind further lung infection during the follow-up period, bronchitis, pneumonia, re-infection with Covid or influenza</p>
      <p>Where any of the patients included treated with inhaled steroids or other inhaled medications during the follow-up period</p>
      <p>Where any of the patients on systemic steroids e.g. for arthritis</p>
      <p>How many of the patients were on oxygen therapy after discharge and for how long time</p>
      <p>**********</p>
      <p><!-- <font color="black"> -->6. PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
      <p>If you choose &#x201C;no&#x201D;, your identity will remain anonymous but your review may still be made public.</p>
      <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.<!-- </font> --></p>
      <p>Reviewer #1:&#xA0;No</p>
      <p>**********</p>
      <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
      <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,&#xA0;<ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at&#xA0;<email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
    </body>
  </sub-article>
  <sub-article article-type="author-comment" id="pone.0302896.r002">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pone.0302896.r002</article-id>
      <title-group>
        <article-title>Author response to Decision Letter 0</article-title>
      </title-group>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0302896" id="rel-obj002" related-article-type="editor-report"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>1</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="author-response-date">21 Mar 2024</named-content>
</p>
      <p>See enclosed cover letter and rebuttal letter</p>
      <supplementary-material id="pone.0302896.s002" position="float" content-type="local-data">
        <label>Attachment</label>
        <caption>
          <p>Submitted filename: <named-content content-type="submitted-filename">rebuttal_letter_plospone_rev1_18mar2024.docx</named-content></p>
        </caption>
        <media xlink:href="pone.0302896.s002.docx"/>
      </supplementary-material>
    </body>
  </sub-article>
  <sub-article article-type="aggregated-review-documents" id="pone.0302896.r003" specific-use="decision-letter">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pone.0302896.r003</article-id>
      <title-group>
        <article-title>Decision Letter 1</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Julie</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>&#xA9; 2024 Julie Zhu</copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>Julie Zhu</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0302896" id="rel-obj003" related-article-type="reviewed-article"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>1</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">16 Apr 2024</named-content>
</p>
      <p>CT abnormalities 3 and 12 months after hospitalization for COVID-19 and association with disease severity: a prospective cohort study</p>
      <p>PONE-D-23-42962R1</p>
      <p>Dear Dr. Stavem</p>
      <p>We&#x2019;re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
      <p>Within one week, you&#x2019;ll receive an e-mail detailing the required amendments. When these have been addressed, you&#x2019;ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
      <p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">Editorial Manager&#xAE;</ext-link>&#xA0;and clicking the &#x2018;Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p>
      <p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they&#x2019;ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p>
      <p>Kind regards,</p>
      <p>Julie Zhu</p>
      <p>Academic Editor</p>
      <p>PLOS ONE</p>
    </body>
  </sub-article>
  <sub-article article-type="editor-report" id="pone.0302896.r004" specific-use="acceptance-letter">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pone.0302896.r004</article-id>
      <title-group>
        <article-title>Acceptance letter</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Julie</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>&#xA9; 2024 Julie Zhu</copyright-statement>
        <copyright-year>2024</copyright-year>
        <copyright-holder>Julie Zhu</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0302896" id="rel-obj004" related-article-type="reviewed-article"/>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">26 Apr 2024</named-content>
</p>
      <p>PONE-D-23-42962R1 </p>
      <p>PLOS ONE</p>
      <p>Dear Dr. Stavem, </p>
      <p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p>
      <p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p>
      <p>* All references, tables, and figures are properly cited</p>
      <p>* All relevant supporting information is included in the manuscript submission,</p>
      <p>* There are no issues that prevent the paper from being properly typeset</p>
      <p>If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. </p>
      <p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p>
      <p>If we can help with anything else, please email us at <email>customercare@plos.org</email>.</p>
      <p>Thank you for submitting your work to PLOS ONE and supporting open access. </p>
      <p>Kind regards, </p>
      <p>PLOS ONE Editorial Office Staff</p>
      <p>on behalf of</p>
      <p>Dr. Julie Zhu </p>
      <p>Academic Editor</p>
      <p>PLOS ONE</p>
    </body>
  </sub-article>
</article>
</pmc-articleset>